NOVONIX Ltd (NVX) Cash & Equivalents (2020 - 2025)

Novonix's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $79.9 million for Q4 2025.

• In Q4 2025, Cash & Equivalents rose 87.67% year-over-year to $79.9 million; the TTM figure through Dec 2025 stood at $79.9 million (up 87.67% YoY), while the FY2025 annual figure was $79.9 million, up 87.67% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $79.9 million, down from $112.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $189.0 million in Q4 2021, with the low at $42.6 million in Q4 2024.
• The 5-year median for Cash & Equivalents is $99.1 million (2022), against an average of $100.1 million.
• The sharpest annual moves came in 2021 and 2024: Cash & Equivalents jumped 294.3% in 2021, then tumbled 52.43% in 2024.
• Novonix's Cash & Equivalents stood at $189.0 million in 2021, then sank by 47.61% to $99.0 million in 2022, then dropped by 20.52% to $78.7 million in 2023, then slumped by 45.93% to $42.6 million in 2024, then soared by 87.67% to $79.9 million in 2025.
• Business Quant data shows NVX's Cash & Equivalents at $79.9 million in Q4 2025, $112.4 million in Q2 2025, and $42.6 million in Q4 2024.